Skip to main content
SpringerLink
Log in

In Reply to “The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease”

  • Letter to the Editor
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

The Original Article was published on 13 June 2015

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  PubMed  Google Scholar 

  2. Horio M, Imai E, Yasuda Y, et al. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56:32–8.

    Article  PubMed  Google Scholar 

  3. Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367:2407–18.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Muto S, Kawano H, Higashihara E, The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. Clin Exp Nephrol. 2015;19:867–77.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors’ appreciate Tadashi Okada and Kazumasa Kishi (Otsuka Pharmaceutical Co., Ltd.) for the discussion on the statistical works.

Author information

Authors and Affiliations

  1. Department of Urology, Juntendo University Graduate School of Medicine, Hongo 3-1-3, Bunkyo-ku, Tokyo, 113-8431, Japan

    Shigeo Horie

  2. Department of Urology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo, 173-8605, Japan

    Satoru Muto

Authors
  1. Shigeo Horie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Satoru Muto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigeo Horie.

Ethics declarations

Conflict of interest

The authors have received honoraria for presentations and research funding from and have consulted and been advisory board members for Otsuka Pharmaceutical.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horie, S., Muto, S. In Reply to “The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease”. Clin Exp Nephrol 20, 149–150 (2016). https://doi.org/10.1007/s10157-015-1154-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1154-7

Keywords

Search

Navigation